Mid-size pharmaceutical companies face unprecedented pressure to accelerate product development timelines while managing rising clinical and regulatory complexity. As pipelines expand and global requirements evolve, these organizations must deliver the same standards as larger competitors, but often without the same internal infrastructure. This gap is accelerating the demand for contract research and development services, which are growing at a 12 to 13% annual increase.
Brian Healey
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Brian
Contact Brian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack